Suppr超能文献

相似文献

1
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions.
Cancer. 2008 Nov 1;113(9):2488-95. doi: 10.1002/cncr.23854.
2
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
Carcinogenesis. 2006 Oct;27(10):2034-7. doi: 10.1093/carcin/bgl048. Epub 2006 Apr 25.
3
Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions.
Eur J Cancer. 2008 Jul;44(11):1603-11. doi: 10.1016/j.ejca.2008.05.006. Epub 2008 Jun 23.
4
Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions.
Cancer. 2009 Apr 1;115(7):1498-506. doi: 10.1002/cncr.24157.
5
Nucleotide excision repair pathway genes and oral premalignant lesions.
Clin Cancer Res. 2007 Jun 15;13(12):3753-8. doi: 10.1158/1078-0432.CCR-06-1911.
7
Genetic variation in MicroRNA genes and risk of oral premalignant lesions.
Mol Carcinog. 2010 Feb;49(2):183-9. doi: 10.1002/mc.20588.
9
Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Cancer. 2008 Jun;112(11):2467-74. doi: 10.1002/cncr.23472.
10
Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study.
Carcinogenesis. 2014 Aug;35(8):1760-4. doi: 10.1093/carcin/bgu093. Epub 2014 Apr 17.

引用本文的文献

2
Diverse roles of bitter melon () in prevention of oral cancer.
J Cancer Metastasis Treat. 2021;7. doi: 10.20517/2394-4722.2020.126. Epub 2021 Mar 9.
3
Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer.
Front Physiol. 2018 Aug 2;9:1014. doi: 10.3389/fphys.2018.01014. eCollection 2018.
5
Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis.
J Dent Res Dent Clin Dent Prospects. 2015 Summer;9(3):166-74. doi: 10.15171/joddd.2015.031. Epub 2015 Sep 16.
6
Combination of genetic variants in cyclin D1 and retinoblastoma genes predict clinical outcome in oral cancer patients.
Tumour Biol. 2016 Mar;37(3):3609-17. doi: 10.1007/s13277-015-4179-3. Epub 2015 Oct 12.
7
Cyclin D1 polymorphism and oral cancer: a meta-analysis.
Mol Biol Rep. 2013 Jan;40(1):87-95. doi: 10.1007/s11033-012-2025-x. Epub 2012 Oct 31.

本文引用的文献

1
Molecular genetics of premalignant oral lesions.
Oral Dis. 2007 Mar;13(2):126-33. doi: 10.1111/j.1601-0825.2006.01349.x.
2
Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma.
Cancer Cell Int. 2006 Dec 19;6:28. doi: 10.1186/1475-2867-6-28.
3
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
Carcinogenesis. 2006 Oct;27(10):2034-7. doi: 10.1093/carcin/bgl048. Epub 2006 Apr 25.
4
Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Dis Colon Rectum. 2006 May;49(5):602-8. doi: 10.1007/s10350-005-0311-6.
5
Cyclin D1: polymorphism, aberrant splicing and cancer risk.
Oncogene. 2006 Mar 13;25(11):1620-8. doi: 10.1038/sj.onc.1209371.
6
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Am J Hum Genet. 2006 Mar;78(3):464-79. doi: 10.1086/500848. Epub 2006 Jan 31.
8
Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Eur Arch Otorhinolaryngol. 2006 Jan;263(1):43-8. doi: 10.1007/s00405-005-0957-7. Epub 2005 Oct 29.
9
Cyclin D1 polymorphism and the risk of endometrial cancer.
Gynecol Oncol. 2005 May;97(2):431-5. doi: 10.1016/j.ygyno.2005.01.023.
10
Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Clin Cancer Res. 2005 Feb 15;11(4):1408-15. doi: 10.1158/1078-0432.CCR-04-1101.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验